FASEB J. Uncover Your Biological Pathway
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cussac, D.
Right arrow Articles by Garbay, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cussac, D.
Right arrow Articles by Garbay, C.
(The FASEB Journal. 1999;13:31-38.)
© 1999 FASEB

Research Communications

A Sos-derived peptidimer blocks the Ras signaling pathway by binding both Grb2 SH3 domains and displays antiproliferative activity

Didier Cussaca, Michel Vidal, Corinne Leprinceb, Wang-qing Liua, Fabrice Cornillea, Gilles Tiraboschia, Bernard P. Roques1 and Christiane Garbaya

a Département de Pharmacochimie Moléculaire et Structurale, INSERM U266-CNRS UMR 8600, UFR des Sciences Pharmaceutiques et Biologiques, 75270 Paris Cedex 06, France
b INSERM U248, Institut CURIE, 75248 Paris Cedex 05, France

With the aim of interrupting the growth factor-stimulated Ras signaling pathway at the level of the Grb2–Sos interaction, a peptidimer, made of two identical proline-rich sequences from Sos linked by a lysine spacer, was designed using structural data from Grb2 and a proline-rich peptide complexed with its SH3 domains. The peptidimer affinity for Grb2 is 40 nM whereas that of the monomer is 16 µM, supporting the dual recognition of both Grb2 SH3 domains by the dimer. At 50 nM, the peptidimer blocks selectively Grb2–Sos complexation in ER 22 (CCL 39 fibroblasts overexpressing epidermal growth factor receptor) cellular extracts. The peptidimer specifically recognizes Grb2 and does not interact with PI3K or Nck, two SH3 domain-containing adaptors. The peptidimer was modified to enter cells by coupling to a fragment of Antennapedia homeodomain. At 10 µM, the conjugate inhibits the Grb2–Sos interaction (100%) and MAP kinase (ERK1 and ERK2) phosphorylation (60%) without modifying cellular growth of ER 22 cells. At the same concentration, the conjugate also inhibits both MAP kinase activation induced by nerve growth factor or epidermal growth factor in PC12 cells, and differentiation triggered by nerve growth factor. Finally, when tested for its antiproliferative activity, the conjugate was an efficient inhibitor of the colony formation of transformed NIH3T3/HER2 cells grown in soft agar, with an IC50 of around 1 µM. Thus, the designed peptidimers appear to be interesting leads to investigate signaling and intracellular processes and for designing selective inhibitors of tumorigenic Ras-dependent processes.—Cussac, D., Vidal, M., LePrince, C., Liu, W.-Q., Cornille, F., Tiraboschi, G., Roques, B. P., Garbay, C. A Sos-derived peptidimer blocks the Ras signaling pathway by binding both Grb2 SH3 domains and displays antiproliferative activity. FASEB J. 13, 31–38 (1999)


Key Words: proline-rich peptidimers • Grb2 SH3 domains inhibition • Sos inhibition




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
A. Jalota-Badhwar, R. Kaul-Ghanekar, D. Mogare, R. Boppana, K. M. Paknikar, and S. Chattopadhyay
SMAR1-derived P44 Peptide Retains Its Tumor Suppressor Function through Modulation of p53
J. Biol. Chem., March 30, 2007; 282(13): 9902 - 9913.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
N. Tapinos and A. Rambukkana
Insights into regulation of human Schwann cell proliferation by Erk1/2 via a MEK-independent and p56Lck-dependent pathway from leprosy bacilli
PNAS, June 28, 2005; 102(26): 9188 - 9193.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
J. K Bonnington and P. A McNaughton
Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor
J. Physiol., September 1, 2003; 551(2): 433 - 446.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. Hosotani, Y. Miyamoto, K. Fujimoto, R. Doi, A. Otaka, N. Fujii, and M. Imamura
Trojan p16 Peptide Suppresses Pancreatic Cancer Growth and Prolongs Survival in Mice
Clin. Cancer Res., April 1, 2002; 8(4): 1271 - 1276.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. C. Pero, L. Oligino, R. J. Daly, A. L. Soden, C. Liu, P. P. Roller, P. Li, and D. N. Krag
Identification of Novel Non-phosphorylated Ligands, Which Bind Selectively to the SH2 Domain of Grb7
J. Biol. Chem., March 29, 2002; 277(14): 11918 - 11926.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
B. K. KAY, M. P. WILLIAMSON, and M. SUDOL
The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains
FASEB J, February 1, 2000; 14(2): 231 - 241.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
M.-F. Carlier, P. Nioche, I. Broutin-L'Hermite, R. Boujemaa, C. Le Clainche, C. Egile, C. Garbay, A. Ducruix, P. Sansonetti, and D. Pantaloni
GRB2 Links Signaling to Actin Assembly by Enhancing Interaction of Neural Wiskott-Aldrich Syndrome Protein (N-WASp) with Actin-related Protein (ARP2/3) Complex
J. Biol. Chem., July 14, 2000; 275(29): 21946 - 21952.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by The Federation of American Societies for Experimental Biology.